Latest Autoantibody Stories
Researchers at National Jewish Health have discovered a type of cell that may contribute to autoimmune disease.
NOVATO, Calif., June 7, 2011 /PRNewswire/ -- BioMarin Pharmaceutical Inc.
Researchers from Harvard Medical School and MIT have developed a new approach for identifying the "self" proteins targeted in autoimmune diseases such as multiple sclerosis, diabetes and rheumatoid arthritis.
DENVER, May 12, 2011 /PRNewswire/ -- OncimmuneÂ® LLC , maker of EarlyCDT(TM)-Lung, a simple blood test that aids physicians in the risk assessment and early detection of lung cancer, today announced that four poster presentations during the American Thoracic Society's (ATS) International Conference May 13 - 18 in Denver will collectively highlight the diagnostic and economic benefits of EarlyCDT-Lung.
Researchers from Boston University School of Medicine (BUSM) have discovered that human proteins with an affinity for Dermatan Sulfate (DS) have the propensity to become autoantigens.
BOSTON, April 15, 2011 /PRNewswire-USNewswire/ -- In the first study investigating the origins of a little-known condition called chronic ulcerative stomatitis (CUS), researchers at Tufts University School of Dental Medicine provide evidence that an autoimmune response contributes to the painful oral sores that characterize the disease.
Scientific advances at The Scripps Research Institute were key to laying the foundation for the new drug BenlystaÂ® (belimumab), approved today by the U.S. Food and Drug Administration. BenlystaÂ®, which treats the most common type of lupus, is the first in a new class of pharmaceuticals that prevents the body from attacking its own critical tissues.
Researchers at Dana-Farber Cancer Institute in Cambridge, Mass., in collaboration with Jackson Laboratory scientists, have identified a regulatory defect that drives lupus.
The presence of antinuclear antibodies (ANA) indicates the possibility of autoimmunity and the indirect immunofluorescence (IIF) assay on HEp-2 cells is the standard blood test (ANA-HEp-2) used to detect ANA.
A new study provides insight into the underlying pathology associated with the autoimmune disease, systemic lupus erythematosus (SLE).